Report post
Biotech ETFs are outperforming the market due to breakthroughs in medical research and treatments. Trading these ETFs requires understanding the sector's volatility and long-term potential. A 20% subsidy on ETFs for retirement savings in some regions is attracting investors. However, investors must weigh the risks and rewards before buying or bailing on biotech ETFs.

The World's Leading Crypto Trading Platform

Get my welcome gifts